Both in Biotechnology
Vericel vs Hemab Therapeutics Holdings
Over the past year VCEL returned +7.2% and COAG returned +9.4%; their daily moves had a correlation of 0.24.
VCEL +7.2% COAG +9.4%Growth of $1, one year, split-adjusted
| Metric | VCEL | COAG |
|---|---|---|
| Price | $41.09 | $43.10 |
| Market cap | $2.10B | $2.01B |
| Today | +1.43% | +4.66% |
| 1 month | 0.0% | +40.9% |
| 6 months | +11.6% | — |
| Year to date | +14.1% | — |
| 1 year | +17.2% | — |
| Revenue growth (YoY) | +22.5% | — |
| Gross margin | 72.8% | — |
| Net margin | 2.8% | — |
| P/E (TTM) | 86.9× | — |
| Price / sales | 6.9× | — |
| Net cash | $162.5M | $457.5M |
| Dividend yield | — | — |
| Volatility (60d) | 32.8% | — |
| Short % of float | 11.1% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).